8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001140361-24-047831
CIK 0001479290operating
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 6:01 AM ET
Size
194.2 KB
Accession
0001140361-24-047831
Documents
- 8-Kef20039245_8k.htmPrimary
8-K
- EX-99.1ef20039245_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHrvnc-20241126.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABrvnc-20241126_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PRErvnc-20241126_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001140361-24-047831-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLef20039245_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 6:01 AM ET
- Size
- 194.2 KB